Navigation Links
Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors
Date:5/16/2013

d markets

• 2012 Sales of branded long-acting recombinant human insulin analogs in regulated markets

• Rhu insulin (2nd generation) in regulated markets

• Biosimilar rhu insulin (2nd generation) in regulated markets

• Rhu insulin analogs (3rd generation) in regulated markets

• Biosimilar rhu insulin analogs (3rd generation) in regulated markets

• Ultra-long acting rhu insulin formulations and insulin analogs (4th generation)

• Ultra-fast acting rhu insulin formulations and insulin analogs (4th generation)

• Combinations of modern basal and prandial insulin & analogs (4th generation)

• Combinations of insulin & GLP-1 agonist (4th generation)

• Other combinations with insulin

• Oral and Transbuccal Insulins (5th generation)

• Inhaled and transdermal insulin

• Novel approaches for insulin therapy

 

Rhu insulin (2nd generation) in non-regulated markets: India

• Rhu insulin (2nd generation) in non-regulated markets: China

• Rhu insulin (2nd generation) in non-regulated markets: Other Territories

• Modern insulin analogs (3rd generation) in non-regulated markets

• Animal insulins (1st generation)

 

6 ) Coagulation Factors

 

• Sales of Recombinant Coagulation Factors for Hemophilia in 2012

• Human Plasma-Derived Coagulation Factor VIII Concentrates

• Recombinant Coagulation Factor VIII

• Human Plasma-Derived Coagulation Factor IX

• Recombinant Coagulation Factor IX

• Human Plasma-Derived Factor VII

• Recombinant Coagulation Factor VII

• Human Plasma-Derived Coagulation Factor Concentrates for Willebrand Disease

• Recombinant Hu
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Cell Therapeutics to Present at Upcoming Investor Conferences
2. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
3. ASGCT Annual Meeting to Highlight Latest Advances in Genetic and Cellular Therapeutics
4. Orexigen Therapeutics Reports Financial Results for the First Quarter Ended March 31, 2013
5. Emergent Technologies and Caisson Biotech Form Strategic Alliance with Local Health Care Providers to Improve Delivery and Performance of a Therapeutic Drug
6. Henri A. Termeer Joins Moderna Therapeutics Board Of Directors
7. Oxford BioTherapeutics and Boehringer Ingelheim Enter Collaboration to Discover Novel Antibody Targets in Cancer
8. Orexigen Therapeutics Commends the Campaign to End Obesitys Report on Long-term Returns of Obesity Prevention Policies
9. Cell Therapeutics to Report First Quarter Financial Results after Market on May 2, 2013
10. United Therapeutics Corporation To Announce First Quarter 2013 Financial Results Before Market Open On Thursday, April 25, 2013
11. Nanotherapeutics Awarded Defense Department Contract for Advanced Development and Manufacturing of Medical Countermeasures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... BETHESDA, Md. , July 2, 2015  Spherix ... committed to the fostering and monetization of intellectual property, ... matter of Spherix Incorporated v. Verizon Services Corp. ... States District Court for the Eastern District of ... Order on July 1, 2015 interpreting certain key claims ...
(Date:7/1/2015)... ... July 01, 2015 , ... It is now possible to ... single photon emission computed tomography (SPECT) according to researchers from Amen Clinics, ... over 20,000 brain scans and is believed to be the largest brain imaging study ...
(Date:7/1/2015)... BANGALORE, India , July 1, 2015 /PRNewswire/ ... uses next generation sequencing technology to empower cancer care, ... as chief executive officer. In his expanded role ... for all strategy, business expansion and worldwide operations effective ... as Strand,s chairman and CEO since its founding in ...
(Date:7/1/2015)... ... 2015 , ... A newly launched business plan contest will ask startup companies ... in life sciences R&D. The Pistoia Alliance President’s Startup Challenge 2015 will see small ... period of expert mentorship from a senior industry figure drawn from the Pistoia Alliance ...
Breaking Biology Technology:Spherix Issues A Litigation Update 2Spherix Issues A Litigation Update 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 4Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3
... ... issues around open source technology are highlighted at leading industry events. , ... Washington, DC (PRWEB) June 11, 2010 -- Open ... Information Association (DIA). The DIA Annual Meeting is the premier event for professionals ...
... , June 11 The Champalimaud Foundation, one ... Dr. J. Anthony Movshon , Director of New ... William T. Newsome , Investigator at The Howard Hughes Medical ... are the recipients of its 2010 Vision Award.  The prestigious ...
... PARIS , June 5, 2010 , ... - One-Year Phase II Data Presented at the 2010 ACTRIMS Meeting , ... Sanofi-aventis (EURONEXT: SAN and NYSE: SNY ... disease modifier,being investigated for the treatment of relapsing multiple sclerosis (RMS).,Study results demonstrated an improvement ...
Cached Biology Technology:Open Source Clinical Trials Software Featured at the 46th DIA Annual Meeting 2Open Source Clinical Trials Software Featured at the 46th DIA Annual Meeting 3Prestigious International Champalimaud Vision Award to US Scientists 2Prestigious International Champalimaud Vision Award to US Scientists 3Prestigious International Champalimaud Vision Award to US Scientists 4Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients 2Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients 3Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients 4Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients 5
(Date:6/30/2015)... , June 30, 2015 To bolster its ... provider HYPR Corp. announced today the addition of two new ... serve as board advisor and David Raviv will ... team underscore HYPR Corp.,s commitment to providing the most secure ... Dimitri Sirota co-founded Layer 7 Technologies, a provider of ...
(Date:6/26/2015)... 26, 2015 ATL Technology, LLC, a top provider ... in single use solutions, headquartered in Springville, Utah ... California corporation with locations in ... Jose, Costa Rica ). This acquisition will ... with ATL Technology,s existing facility in Costa ...
(Date:6/25/2015)... , June 25, 2015  TAKE Solutions Ltd., ... patent by the United States Patent and Trademark Office ... This process leverages TAKE Solutions, Clinical Accelerators to reduce ... 50% (when compared to standardization without the accelerators), thus ... At the heart of the ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2TAKE Solutions Awarded Patent By USPTO 2
... Most Severe Droughts in Last Thousand Years: ... greatly over the past two decades in the ... fire regimes and forest patterns over the past ... vegetation trends. Specifically, these sources show that regional ...
... large-scale analysis of the association between DNA viruses and human ... not associated with DNA viruses. The findings, published in ... , challenge earlier studies suggesting as high as 40 percent ... believed viruses played a role in the development of maybe ...
... mixing lego bricks of two different sizes is child,s ... made of heterogeneous blocks is anything but straightforward. Theoretical ... UK, studies polymer mixes consisting of two-fold (AB) and ... He has shown, in a study published in ...
Cached Biology News:USGS science at the Ecological Society of America 2USGS science at the Ecological Society of America 3USGS science at the Ecological Society of America 4USGS science at the Ecological Society of America 5USGS science at the Ecological Society of America 6USGS science at the Ecological Society of America 7USGS science at the Ecological Society of America 8Percentage of cancers linked to viruses potentially overestimated 2Heterogeneous nanoblocks give polymers an edge 2
Hamster serum...
... Reactive Dye Pack, 12 x Cy5. ... optimized for microarray labeling.Higher reactivity Cy3 ... dye per vial, at > 75% ... dispensed, and packed in foil packs ...
Collected from sexually mature, mixed sex, mixed breed dogs. Serum from specific breeds available by request....
... EPS 301 Power Supply, 1. ... maximum.Constant voltage or constant current modes.Single-unit ... precision and reproducibility.Suitable for submarine, mini ... as well as semidry and mini ...
Biology Products: